Medicare billing address
CMS Medicare provider billing file
48 Tunnel RdSuite 203
Pottsville, PA 17901
CMS public data · NPI 1417155151
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Mark D Brayford, D.O.
Specialty
Credential
D.O.
NPI
1417155151
Primary source state
PA
Data retrieval date
July 28, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Mark D Brayford, D.O. from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
48 Tunnel RdCMS Doctors & Clinicians file
2000 Westinghouse DrCMS Doctors & Clinicians file
48 Tunnel RdIn the 2024 CMS provider billing file, this NPI had 424 Medicare beneficiaries and 25,334 total services. The average beneficiary age was 74, and the average HCC risk score was 1.
Total Medicare allowed amount
$259,007.05
Total Medicare payment amount
$196,421.37
Medicare beneficiaries
424
Total services
25,334
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hyperlipidemia
75%
CMS beneficiary-panel share
Hypertension
75%
CMS beneficiary-panel share
Anxiety
31%
CMS beneficiary-panel share
Diabetes
27%
CMS beneficiary-panel share
Ischemic heart disease
26%
CMS beneficiary-panel share
Chronic kidney disease
25%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Injection, methylprednisolone acetate, 1 mg | 18,361 | $0.13 |
| Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg | 3,888 | $17.20 |
| Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg | 1,056 | $17.36 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 594 | $120.44 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 569 | $111.60 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 186 | $0.94 |
| Injection, methylprednisolone acetate, 40 mg | 90 | $6.33 |
| New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more | 88 | $104.62 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 56 | $13.23 |
| New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more | 27 | $158.27 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1417155151. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Celecoxib | Celecoxib | 72 | 86 | $2,714.03 |
| 2 | Meloxicam | Meloxicam | 56 | 89 | $330.07 |
| 3 | Tramadol Hcl | Tramadol Hcl | 45 | 45 | $103.99 |
| 4 | Prednisone | Prednisone | 38 | 38 | $127.22 |
| 5 | Diclofenac Potassium | Diclofenac Potassium | 17 | 19 | $403.57 |
| 6 | Oxycodone Hcl | Oxycodone Hcl | 14 | 14 | $76.62 |
| 7 | Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 14 | 14 | $185.08 |
| 8 | Amlodipine Besylate | Amlodipine Besylate | 12 | 36 | $131.39 |
| 9 | Lisinopril | Lisinopril | 12 | 36 | $145.84 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Medical school
Philadelphia College Of Osteopathic Medicine
Graduation year
2003
Group/practice field
Phoenix Rehabilitation And Health Services Inc
Telehealth reported
Yes
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.